Endocrine Abstracts

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease and has an estimated prevalence of 25–30% worldwide, rising to 90% in morbidly obese patients and to 60% in patients with type 2 diabetes (T2D). The mortality related to NAFLD, attributed to hepatic and extra-hepatic diseases, continues to increase. Moreover, T2D is an aggravating factor for NAFLD, as it increases the risk of developing non-alcoholic steatohepatitis (NASH), liver f...

Non-alcoholic fatty liver disease (NAFLD) is commonly associated with obesity, metabolic syndrome and type 2 diabetes. NAFLD is also seen in patients with endocrinopathies. However, the relationship between endocrinopathies and the development of NAFLD is not well known. Both GH and IGF1 are believed to be involved in the regulation of hepatic lipid metabolism.Objective: In this study, we set out to determine whether liver fat content (LFC) was associate...